Depressed Jane

Valdoxan® today received a positive opinion from the European Medicines Agency’s (EMEA) Committee for Medicinal Products for Human Use (CHMP) for its use in the treatment of adult patients with Major Depressive Episodes (MDE).1 Valdoxan is an innovative approach to the treatment of MDE and has demonstrated convincing efficacy in depressed patients with moderate-severe depression2, offering new hope to many of the more than 2.

Popularity: 1% [?]

Scientists at the University of Liverpool have developed a therapy programme to treat depression in women in developing countries. Although depression is a major health problem world-wide, experts say its impact is greatest in developing countries where 80% of the population live. Often there are no resources available to treat sufferers.

Popularity: unranked [?]

People who have attempted suicide at some point in their lives are more likely to actually succeed in committing suicide at a later date. The risk is particularly high for people with serious psychiatric disorder, according to a new study from the Swedish medical university Karolinska Institutet. One in ten suicide attempters actually commit suicide later on in life.

Popularity: unranked [?]

NHS and MOD collaborate to provide mental health care closer to home. A Somerset mental health Trust is one of only seven organisations selected by the Ministry of Defence to support members of the armed services affected by mental ill health.

Popularity: unranked [?]

The American College of Physicians is publishing a new guideline for the treatment of depression in Annals of Internal Medicine. ACP found no substantial differences in efficacy or quality of life among “second-generation” antidepressants used to treat depressive disorders such as major depressive disorder.

Popularity: unranked [?]

The latest Department of Health (DOH) data report on youth shows that an estimated 7,300 of Hawai’i’s public high school students are obese (15.6%). Additionally, an estimated 5,600 students reported attempting suicide within the past year, a statistic that shows Hawai’i’s youth are at greater risk than the national average. However, the findings of the Youth Risk Behavior Survey (YRBS) showed Hawai’i youth’s decline in risky health behaviors, such as tobacco, alcohol and other drug use.

Popularity: unranked [?]

1. New ACP Guideline Looks at Effectiveness of Drugs Used to Treat Depressive Disorders Second generation treatments for depression are all equally effective according to a new clinical practice guideline from the American College of Physicians (ACP). The guideline is published today in Annals of Internal Medicine, the ACP’s flagship journal.

Popularity: unranked [?]

CNS Response, Inc. (OTCBB: CNSO) reported today the results of a study presented at the U.S. Psychiatric and Mental Health Congress by Daniel Hoffman, M.D., Chief Medical Officer for CNS Response.

Popularity: 1% [?]

Results of a new study call into question recent clinical guidelines issued by leading cardiovascular groups, including the American Heart Association, which recommend patients with cardiovascular disease be screened for signs of depression and treated accordingly. The study, published in the November 12 edition of the Journal of the American Medical Association and conducted by an international team of researchers including James Coyne, Ph.D.

Popularity: unranked [?]

Clinicians and researchers from around the world attended this week’s 8th International Forum on Mood and Anxiety disorders in Vienna, Austria to discuss the latest advances in the treatment of mood disorders. A wide range of topics were included in this year’s programme, highlighting the position of IFMAD in the congress calendar as a forum for breaking news, original thinking and debate.

Popularity: 1% [?]